Research into underwater noise and continued technology development are helping address key risks that have slowed the commercial expansion of tidal energy in the UK...
As wind and solar expand, long duration storage technologies such as vanadium flow batteries are gaining attention as tools for managing intermittent power generation...
Predictive analytics is enabling Medical Affairs teams to identify emerging clinical discussions earlier and engage the most relevant healthcare professionals...
Geopolitical tensions and speculation around artificial intelligence are reshaping market sentiment and highlighting the importance of diversification for investors...
Energy market disruption from geopolitical conflict is pushing oil prices higher and raising concerns about inflation, interest rates and economic growth...
Marshalls plc will host a live interactive presentation for investors on 20 March 2026 via the Engage Investor platform, following the release of its Final Results on 16 March...
Domino’s Pizza Group posted modest sales growth in FY2025 and strong cash generation, supporting a higher dividend. The company said trading in early 2026 remains in line with market expectations..
Grafton Group has agreed to acquire Irish offsite timber frame supplier Cygnum Holdings, strengthening Chadwicks Group’s offering and expanding its exposure to Ireland’s growing modular housing market...
Jonathon Bond will join the ICG Board on 1 April 2026 and serve on the Remuneration Committee, as Stephen Welton and Rosemary Leith announce plans to retire at the July..
Spirax Group reported 2025 revenue of £1.7bn, up 5% organically and ahead of global industrial production. Adjusted operating profit rose 6%, while statutory profit declined due to restructuring costs...
Persimmon increased completions, revenue and profits in 2025, with housing revenue up 16% to £3.31bn. The company expects 12,000–12,500 completions in 2026, supported by strong forward sales and improved market..
The FDA has granted Orphan Drug Designation to tranilast lystate, the active compound in Nuformix’s NXP002 programme targeting idiopathic pulmonary fibrosis, a rare lung disease affecting fewer than 200,000 people..
Research into underwater noise and continued technology development are helping address key risks that have slowed the commercial expansion of tidal energy in the UK...
As wind and solar expand, long duration storage technologies such as vanadium flow batteries are gaining attention as tools for managing intermittent power generation...
Predictive analytics is enabling Medical Affairs teams to identify emerging clinical discussions earlier and engage the most relevant healthcare professionals...
Geopolitical tensions and speculation around artificial intelligence are reshaping market sentiment and highlighting the importance of diversification for investors...
Energy market disruption from geopolitical conflict is pushing oil prices higher and raising concerns about inflation, interest rates and economic growth...
Marshalls plc will host a live interactive presentation for investors on 20 March 2026 via the Engage Investor platform, following the release of its Final Results on 16 March...
Domino’s Pizza Group posted modest sales growth in FY2025 and strong cash generation, supporting a higher dividend. The company said trading in early 2026 remains in line with market expectations as it focuses on core growth, digital expansion, and operational efficiency...
Grafton Group has agreed to acquire Irish offsite timber frame supplier Cygnum Holdings, strengthening Chadwicks Group’s offering and expanding its exposure to Ireland’s growing modular housing market...
Jonathon Bond will join the ICG Board on 1 April 2026 and serve on the Remuneration Committee, as Stephen Welton and Rosemary Leith announce plans to retire at the July 2026 AGM...
Spirax Group reported 2025 revenue of £1.7bn, up 5% organically and ahead of global industrial production. Adjusted operating profit rose 6%, while statutory profit declined due to restructuring costs...
Persimmon increased completions, revenue and profits in 2025, with housing revenue up 16% to £3.31bn. The company expects 12,000–12,500 completions in 2026, supported by strong forward sales and improved market conditions...
The FDA has granted Orphan Drug Designation to tranilast lystate, the active compound in Nuformix’s NXP002 programme targeting idiopathic pulmonary fibrosis, a rare lung disease affecting fewer than 200,000 people in the United States...
